NCT03775668View on ClinicalTrials.gov

Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

December 5, 2018

Study Completion Date

January 31, 2019

Conditions

Healthy

Interventions

DRUG

1 µCi of 14C-AAI101 + 500 mg AAI101

Single dose open label

Trial Locations (1)

21201

Pharmaron Clinical Pharmacology Center, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allecra

INDUSTRY